Literature DB >> 9672217

The protection of the retina from ischemic injury by the free radical scavenger EGb 761 and zinc in the cat retina.

S Y Kim1, J S Kwak, J P Shin, S H Lee.   

Abstract

We investigated the effects of a free radical scavenger (EGb 761) and zinc in experimentally induced ischemic injury in the cat retina. Total retinal ischemia for 90 min was produced in the left eyes of 40 cats by raising intraocular pressure. In group 1, 10 cats were used as control. The free radical scavenger (EGb 761, 100 mg/kg) in group 2 (10 cats) and zinc chloride (250 microg/kg) in group 3 (10 cats) were administered intravenously at the end of ischemia. In group 4, both EGb 761 (100 mg/kg) and zinc chloride (250 microg/kg) were injected into 10 cats. ERG and a histologic study were performed 1 h, 1 day, 3 days, 1 week and 2 weeks after ischemia. The amplitude of the ERG b-wave was 62.73+/-0.32, 84.31+/-6.10, 83.65+/-12.23 and 102.4+/-14.27%, and the summed amplitude of oscillatory potentials was 66.16+/-16.42, 99.44+/-14.92, 95.45+/-6.42 and 99.62+/-12.32% in each group 2 weeks after ischemia. There was no significant effect in animals that received zinc alone (group 3) by the end of 1 week but some additive effect in combining EGb 761 and zinc chloride (group 4) 1 h after ischemia. These findings suggest that the free radical scavenger EGb 761 may efficiently protect the retina from ischemic injury and zinc may have an additive effect when combined with a radical scavenger.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672217     DOI: 10.1159/000027305

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  10 in total

Review 1.  Neuroprotection in glaucoma: drug-based approaches.

Authors:  William Cheung; Li Guo; M Francesca Cordeiro
Journal:  Optom Vis Sci       Date:  2008-06       Impact factor: 1.973

Review 2.  Protecting retinal ganglion cells.

Authors:  T Z Khatib; K R Martin
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

Review 3.  Nutritional recommendations for individuals with Flammer syndrome.

Authors:  Zakieh Vahedian; Ghasem Fakhraie; Jerome Bovet; Maneli Mozaffarieh
Journal:  EPMA J       Date:  2017-05-29       Impact factor: 6.543

Review 4.  Pharmacological neuroprotection for glaucoma.

Authors:  Glyn Chidlow; John P M Wood; Robert J Casson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  The protective effect of EGB761 on vessels of denervated gastrocnemius in rats and its mechanism.

Authors:  Dongyi Zhang; Rui Wu; Hao Kang; Guangxiang Hong; Shensong Kang; Zhengwen Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

Review 6.  Potential of the bioflavonoids in the prevention/treatment of ocular disorders.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  J Pharm Pharmacol       Date:  2010-08       Impact factor: 3.765

7.  Delivery of antioxidant enzyme genes to protect against ischemia/reperfusion-induced injury to retinal microvasculature.

Authors:  Baihua Chen; Sergio Caballero; Soojung Seo; Maria B Grant; Alfred S Lewin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

8.  Ciprofloxacin-collagen conjugate in the wound healing treatment.

Authors:  Francesco Puoci; Cristiana Piangiolino; Francesco Givigliano; Ortensia Ilaria Parisi; Roberta Cassano; Sonia Trombino; Manuela Curcio; Francesca Iemma; Giuseppe Cirillo; Umile Gianfranco Spizzirri; Donatella Restuccia; Rita Muzzalupo; Nevio Picci
Journal:  J Funct Biomater       Date:  2012-05-15

9.  An Innovative In Vitro Open-Angle Glaucoma Model (IVOM) Shows Changes Induced by Increased Ocular Pressure and Oxidative Stress.

Authors:  Stefania Vernazza; Sara Tirendi; Mario Passalacqua; Francesco Piacente; Sonia Scarfì; Francesco Oddone; Anna Maria Bassi
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

Review 10.  Vitreous mediators in retinal hypoxic diseases.

Authors:  Roberto dell'Omo; Francesco Semeraro; Giulio Bamonte; Francesco Cifariello; Mario R Romano; Ciro Costagliola
Journal:  Mediators Inflamm       Date:  2013-01-10       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.